Navigation Links
RSA Designated as the Leader in One-Time Password Market by Frost & Sullivan
Date:6/19/2009

EMC's Security Division Recognized as Only 'Market Leader' in One-Time Passwords for Highest Ability to Execute and Market Penetration

BEDFORD, Mass., June 19 /PRNewswire/ -- RSA, The Security Division of EMC (NYSE: EMC) announced that the Frost & Sullivan white paper entitled, An Overview and Competitive Analysis for the One Time Password Market*, designates RSA as the sole market leader in one-time password (OTP) technology for strong authentication based upon the highest ability to execute and deep market penetration. Frost & Sullivan forecasts the global OTP market will reach $690.4 million in 2015.

According to Frost & Sullivan, "Authentication remains a priority for RSA, where it maintains leadership in OTP and risk-based authentication. RSA continues to expand and innovate the RSA SecurID OTP portfolio to include mobile software tokens, SMS authentication, hybrid authenticators and virtual credentials as well as biometric and USB Flash solutions, allowing organizations to choose the solution that best meets their user, risk and security requirements."

The white paper also noted, "RSA continues to invest in the RSA(R) Authentication Manager server for robust administration, credential lifecycle management and end user self-service as tools for organizations to manage support costs. The combination of RSA SecurID, risk-based and knowledge-based authentication provides companies with the tools they need to create the most appropriate layered solution for their organization."

"The RSA SecurID two-factor authentication system is used by over 40,000,000 people and is supported by thousands of technology and channel partners worldwide. As a result, RSA is well positioned to continue leading the way in helping organizations protect identities, infrastructures and information agai
'/>"/>

SOURCE EMC Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. SNMs clinical trials network gains added support from industry leader
2. Scientists urge world leaders to respond cooperatively to Pacific Ocean threats
3. Regional partnership to develop algal biofuels gets backing of San Diego leaders
4. AIBS names 2009 emerging public policy leaders
5. Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing
6. Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing
7. Massague honored with inaugural AACR Distinguished Leadership Award in Breast Cancer Research
8. CIC Teams With Industry Leader iPipeline to Provide Electronic Signature Platform to the Nations Top Insurance Carriers
9. PNNL leadership in carbon sequestration featured at international conference
10. Fish choose their leaders by consensus
11. Following the leader can be a drag, according to students research on flapping flags
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... at Albert Einstein College of Medicine of ... J. Fox Foundation for Parkinson,s Research to translate a ... This drug discovery project will test chemical compounds on ... a drug that acts on an underlying cause of ... help many people manage their symptoms, we are eager ...
(Date:7/24/2014)... NJIT this week for an all-day public forum on ... Agency (EPA) to dredge toxic sediment from an eight-mile ... has called the plan, which proposes removing 4.3 million ... the riverbed, one of the largest cleanups in the ... disposed off-site. , "We need to ensure the future ...
(Date:7/24/2014)... researchers and patients have hoped that embryonic stem cells ... bodycould provide insight into numerous diseases perhaps even be ... by the inability to transfer research and tools from ... because human ESCs are "primed" and slightly less plastic ... Powell, and Haoyi Wang, who are scientists in the ...
Breaking Biology News(10 mins):Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2
... Imagine a polka-dotted postage stamp that can sniff out poisonous ... reported in the Sept. 13 issue of the journal ... University of Illinois have developed an artificial nose for the ... fast and inexpensive and works by visualizing odors. ...
... The master gene that causes blood stem cells to ... identified by scientists, in a study published in Nature ... boost the body,s production of these frontline tumour-killing cells, creating ... ,knocked out, the gene in question, known as E4bp4, in ...
... a widespread and expensive social problem. Recent research ... interaction between genetic inheritance and environment for development ... common knowledge that childhood maltreatment often causes psychiatric ... (e.g. aggression or antisocial behaviour) later in life. ...
Cached Biology News:Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Master gene that switches on disease-fighting cells identified by scientists 2Master gene that switches on disease-fighting cells identified by scientists 3Are the monoamines involved in shaping conduct disorders? 2Are the monoamines involved in shaping conduct disorders? 3Are the monoamines involved in shaping conduct disorders? 4Are the monoamines involved in shaping conduct disorders? 5Are the monoamines involved in shaping conduct disorders? 6
(Date:7/25/2014)... Israel , July 25, 2014  Galmed Pharmaceuticals ... biopharmaceutical company focused on the development and commercialization of ... diseases and cholesterol gallstones, today announced financial results for ... Half 2014 Financial Summary: , Reported cash and ... compared with $137,000 at December 31, 2013.  , ...
(Date:7/24/2014)... New York, NY - July 24, 2014 -- Keryx ... results from the long-term, randomized, active control Phase 3 ... ferric iron-based phosphate binder, for the treatment of hyperphosphatemia ... The PERFECTED study (PhosphatE binding and iRon delivery with ... the Journal of the American Society of Nephrology ...
(Date:7/24/2014)... 24, 2014  Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), ... of regenerative medicine, announced today that it will ... investors on Tuesday, July 29, 2014, at 4:30 ... include an overview of Asterias, business strategy and ... http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 minutes before ...
(Date:7/24/2014)... yet to materialise. Yet, scientists are making progress ... faster. One such approach relies on quantum dotsa ... an electric field. A new study demonstrates that ... dots (TQDs) with electrical impulses can help better ... TQDs be used as quantum information units, which ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... Germany and MINNEAPOLIS, Minnesota, February 11, Bayer HealthCare ... Minneapolis, MN, (Nasdaq: POSS ), announced today ... pursuant to which,MEDRAD will acquire Possis Medical in ... or a total equity value of approximately US-Dollar ...
... Feb. 11 Replikins Ltd. announced that the,quantitative ... structure,predicts that the current H5N1 cycle is over. ... and high mortality characteristics,are expected to subside - ... or,another influenza virus strain begins., 140,000 virus ...
... Cryo-Cell,International, Inc. (OTC Bulletin Board Symbol: CCEL) (the ... family cord blood banks, today,announced results for fiscal ... ended November 30, 2007 were,approximately $17.5 million, up ... ended November 30, 2006. The Company reported a ...
Cached Biology Technology:Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 2Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 3Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 4Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 5Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 6FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over 2Cryo-Cell International, Inc. Reports Results for Fiscal 2007 2Cryo-Cell International, Inc. Reports Results for Fiscal 2007 3Cryo-Cell International, Inc. Reports Results for Fiscal 2007 4Cryo-Cell International, Inc. Reports Results for Fiscal 2007 5Cryo-Cell International, Inc. Reports Results for Fiscal 2007 6
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... large numbers of samples may be carried out ... operator attention. System control and data processing ... 4900. The elegant, powerful and very easy ... Windows 98 and 2000., The supplied detector is ...
Narrow-mouth has heavy-duty rim. Approximate graduations are in durable white enamel. Extra large marking space. capacity 125 mL Special grade: student grade...
Biology Products: